The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for LifeScience PLUS sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
LifeScience PLUS is an advanced wound care technology company. The company develops and markets novel wound care solutions for the treatment of moist dressing, contamination prevention, hemostasis (bleeding control), sealant, and fast tissue growth generation. The company’s major product, Bloodstop provides both acute and chronic wound care for burn and trauma surgeries, and diabetic ulcer and decubitus wounds. It also offers Bloodstop OTC, hemostatic dressing, hemostatic assist compression dressing and arc extremity stabilizer positioner. LifeScience PLUS is headquartered in Mountain View, California, the US.
The key metrics of LifeScience PLUS related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As LifeScience PLUS is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as LifeScience PLUS.
For a detailed understanding of the performance of LifeScience PLUS, buy the report here.